Trial Profile
A Phase II, Randomized, Single Center, Pilot Feasibility Study to Evaluate Naloxegol for Opioid-Induced Constipation in Cancer Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2019
Price :
$35
*
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 30 Aug 2019 Status changed from recruiting to discontinued.
- 27 Feb 2017 Status changed from not yet recruiting to recruiting.
- 25 Apr 2016 New trial record